On 9 and 10 June, NCMBM gathered at the Klækken Hotel in Hønefoss for two days of scientific talks, networking and community building.
The two-day retreat brought together around 80 participants to exchange knowledge, strengthen collaborations and connect with colleagues across the Centre.
A new study co-led by researchers at the Norwegian Centre for Molecular Biosciences and Medicine (NCMBM), and at the University of Helsinki has identified the protein SIT1 as a critical regulator of T cell activation and immune balance in humans. The findings, published in the Journal of Allergy and Clinical Immunology, provide important new insights into how the immune system is controlled and how disruptions in these mechanisms can contribute to immunodeficiency and cancer.
This study is the result of an international collaboration between researchers from Finland, Norway, Germany, and Austria.
The Nordic EMBL Partnership for Molecular Medicine has appointed Janna Saarela as its new Speaker, effective January 2026. Janna Saarela is the Director of the Norwegian Centre for Molecular Biosciences and Medicine (NCMBM) and succeeds Oliver Billker from the Laboratory for Molecular Infection Medicine Sweden (MIMS) in representing the Partnership internationally.
ELIXIR has announced the life science data resources selected in its latest evaluation round for ELIXIR Core Data Resources (CDRs) and ELIXIR Deposition Databases.
Among the six newly approved Core Data Resources is JASPAR, a long-standing and widely used database for transcription factor binding profiles, with the work behind the resource currently led by Anthony Mathelier, Associate Director and Group Leader of the Computational Biology & Gene Regulation group at the Norwegian Centre for Molecular Biosciences and Medicine (NCMBM).
